Clifford Capital Partners Fund Institutional Class
CLIFX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Clifford Capital Partners Fund Institutional Class (CLIFX) is an open-end mutual fund seeking long-term capital appreciation through a bottom-up value investment strategy focused on undervalued U.S. equities across large-, mid-, and small-cap companies. The fund employs a blend of Core Value stocks, which feature high returns on capital, sustainable competitive advantages, and strong management teams (typically comprising 50-75% of the portfolio), and Deep Value stocks, which exhibit negative market sentiment, defensible franchise value, and high expected return potential (along with cash, comprising 25-50%); it maintains a concentrated portfolio of 25-35 holdings with high active share versus the Russell 3000 Value Index benchmark. As of September 30, 2025, total net assets stand at approximately $134 million across share classes, with top holdings including Solventum Corp (4.4%), Henry Schein Inc (4.3%), NCR Atleos Corp (4.2%), Johnson & Johnson (4.2%), and Becton Dickinson and Co (4.0%), diversified across sectors such as healthcare, financials, industrials, and communication services. Managed by Clifford Capital Partners, LLC, an independent investment management firm founded in 2010 and headquartered in Alpine, Utah, the fund was incepted on January 30, 2014, with CUSIP 98147A246 and a net expense ratio of 0.90% (contractually reduced until January 31, 2026). It primarily targets institutional investors with a $100,000 minimum initial investment and operates daily pricing for redemptions, domiciled in the United States and available for sale therein. The investment team, led by portfolio manager Ryan Batchelor since inception, utilizes proprietary fundamental research to identify stocks trading at meaningful discounts to intrinsic value based on Key Thesis Points for long-term catalysts. Recent portfolio adjustments in the fourth quarter of 2024 included the addition of two new Core Value holdings: Henry Schein Inc (HSIC, 2.56% of the fund at December 31, 2024) and Keurig Dr Pepper (KDP, 2.95% at quarter-end), reflecting ongoing opportunistic shifts to enhance undervaluation exposure amid market volatility. The adviser maintains a disciplined approach with a one-year trailing turnover of 71.5% as of September 30, 2025, supporting portfolio evolution without major strategic pivots, funding rounds, or acquisitions reported for the firm or fund in the past 1-2 years. Total assets remained stable near $134-139 million through 2025, underscoring consistent operational focus on all-cap value equities for institutional and individual clients globally via separate accounts and this flagship fund.